Home
Home

Ironwood

The Compelling Science Behind Synergy

The Compelling Science Behind Synergy
Seeking Alpha

Ironwood's Bowel Drug Sales Disappoint

Ironwood's Bowel Drug Sales Disappoint
TheStreet.com

Synergy Pharmaceutical Could Almost Double In Value With Plecanatide

Synergy Pharmaceutical Could Almost Double In Value With Plecanatide
Seeking Alpha

Ironwood Implies Upside For Synergy; Lessons Learned From Dendreon

Ironwood Implies Upside For Synergy; Lessons Learned From Dendreon
Seeking Alpha

Patent Licensure Positive, Removes Barrier To Potential SGYP Pharma Partnership

Patent Licensure Positive, Removes Barrier To Potential SGYP Pharma Partnership
Yahoo/Reuters

Synergy Pharmaceuticals: Positioning For Pipeline Payoff

Synergy Pharmaceuticals: Positioning For Pipeline Payoff
Seeking Alpha

Ironwood: FDA Approval Makes the Price Right for This Pharma Stock

Ironwood: FDA Approval Makes the Price Right for This Pharma Stock
Motley Fool

FDA approves Ironwood, Forest Labs bowel drug

FDA approves Ironwood, Forest Labs bowel drug
Yahoo/AP

Ironwood Pharma: FDA Decision Expected Within Weeks For GI Drug

Ironwood Pharma: FDA Decision Expected Within Weeks For GI Drug
Seeking Alpha

28 Drugs Facing FDA Approval in 2012-2013

28 Drugs Facing FDA Approval in 2012-2013
TheStreet.com